Terms ending in 2029
Every in-force patent on Sanofi's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,569,535 | Substituted BENZOYLAMINO-INDAN-2-Carboxylic Acids and Related Compounds In force · High confidence | Sanofi | In force | High confidence | |
| US 8,518,875 | (CARBOXYLALKYLENEPHENYL)PHENYLOXAMIDES, Method for the Production Thereof and Use of Same as a Medicament In force · High confidence | Sanofi | In force | High confidence | |
| US 8,211,867 | Targeting Micrornas for the Treatment of Liver Cancer In force · High confidence | Sanofi | In force | High confidence | |
| US 8,378,092 | Chlorothiophene-Amides as Inhibitors of Coagulation Factors Xa and Thrombin In force · High confidence | Beijing Lianxin Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 8,003,387 | In Vitro Germinal Centers In force · High confidence | Sanofi Pasteur Vaxdesign Corporation | In force | High confidence | |
| US 8,268,828 | Inhibitors of the Chemokine Receptor CXCR3 In force · High confidence | Sanofi | In force | High confidence | |
| US 11,453,727 | Antibodies That Bind IL-4 And/Or IL-13 and Their Uses In force · High confidence | Sanofi | In force | High confidence | |
| US 8,119,813 | Method for Preparing Enantiomerically Enriched N-Carboxyanhydride In force · High confidence | ImmunoGen, Inc. | In force | High confidence | |
| US 9,295,721 | Process For Stabilizing An Adjuvant Containing Vaccine Composition In force · High confidence | Sanofi Pasteur S.A. | In force | High confidence | |
| US 9,878,028 | Process For Stabilizing An Adjuvant Containing Vaccine Composition In force · High confidence | Sanofi Pasteur S.A. | In force | High confidence | |
| 34 more term ends in 2029 · Pro | |||||
10 of 44 patents shown. Soonest term end first, then patent number.
Pro members see all 44.
38 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.